Is BioMarin Still An Outperform At This Research Firm?

By: via Benzinga
In a report published Friday, Cowen and Company analysts maintained an Outperform rating on BioMarin Pharmaceutical Inc. (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.